Pharmaceutical giant AstraZeneca has dismissed reports in German media claiming that the AstraZeneca/Oxford COVID-19 vaccine was largely ineffective on elderly people above 65. “Reports that the AstraZeneca/Oxford vaccine efficacy is as low as 8% in adults over 65 years are completely incorrect,” an AstraZeneca spokesperson told DW in a written response. The company said that an influential UK vaccination committee, the JCVI, and the UK’s national MHRA medicines regulator supported the use of its vaccine on that particular age group. “In November, we published data in The Lancet demonstrating that older adults showed strong immune responses to the vaccine, with 100% of …
